University of Nebraska: Prostatic Neoplasms trials
The registry lists 12 Prostatic Neoplasms studies with University of Nebraska as lead sponsor. 7 are open to participants now and 2 have results posted.
Phase 1 3Phase 2 7Phase 3 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate CancerNot yet recruitingNCT07882862Phase 2
- COQ10 and Vitamin E for Off-Target Radiation ToxicityNot yet recruitingNCT07668284Phase 1/2
- Whole Versus Partial Gland Boost During Prostate SBRTNot yet recruitingNCT07574489Phase 2/3
- Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate CancerRecruitingNCT07237269Phase 2
- PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate CancerRecruitingNCT07234981Phase 2
- High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate CancerRecruitingNCT05754580Not applicable
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate CancerTerminatedNCT01093183Phase 1/2Results posted
- Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00483561Phase 2Results posted
- Strength, Aging, and Memory in Prostate CancerCompletedNCT04852224
- Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation TherapyWithdrawnNCT01555632Not applicable
- Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate CancerCompletedNCT00482807Phase 1